News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
32
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
784
|
|
Created
|
01/21/05
|
Type
|
Free
|
| Moderators | |||
Probiotic Solutions
Pure Botanicals
Functional Beverages
Acidophilus bacterium
Hemp oil
Cannabidiol (CBD)
Rik J. Deitsch | Chairman and Chief Executive Officer
Rik J. Deitsch has been the President, Chief Executive Officer and a Director of Nutrapharma, a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases since November 7, 2002. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. Mr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic . Mr. Deitsch is an adjunct professor and teaches several courses for Florida Atlantic University’s College of Business and Continuing Education Department.
John George Michak III | COO
As a Nordstrom’s credit communications planner from April 2013 to January 2014, Mr. Michak supported the development of business operational documents and drove the execution for all credit related customers facing collateral. Managed the collateral budget and worked with colleagues to identify and implement customer communications enhancements and or cost reduction opportunities for the company. While at Morgan Stanley Global Wealth Management from January 2012 to January 2013, Mr. Michak worked as a technology analyst, and as a strategic partner along with the firm’s business units and some of the world’s leading technology companies to redefine how Morgan Stanley does business in global financial markets that are extremely fast and vastly complex. While assisting the firm with the conversion effort of combining Smith Barney and Morgan Stanley to create Morgan Stanley Global Wealth Management Group. Mr. Michak also worked for Alpert Homes from March 2010 to January 2012 and helped manage relationships with sales center representatives in assigned communities and followed up regularly regarding prospects. He also assisted in managing new home construction sites start to finish.
Mr. Michak holds a liberal arts degree from Colorado State University as well as attended Kaplan real estate school in Denver. He has been working with global companies aiding in their growth and expansion since 2009.
Dr. M.S. Reddy
Dr. Reddy is founder and president of Denver-based American Dairy and Food Consulting Laboratories and International Media and Cultures (IMAC Inc.) which has ten manufacturing plants selling, products throughout the United States, Canada, Europe, India and Latin America. He was nominated for the Nobel Peace Prize in 2012, 2013 and 2014. He holds over 150 U.S. and international patents and has published over 70 scientific articles on dairy starter cultures, probiotics, pharmaceuticals, and complementary alternative medicines pertaining to Probiotics and has authored several books.
Dr. Reddy has served as a technical consultant to over 70 national and international companies all over the world including industry related Domino’s Pizza and Papa Johns. He has received many awards in scientific research, community service, and entrepreneurship including the Richard Hoyt award, Sigma-Xi Research award, Outstanding Scientist award, Entrepreneur and Businessman of the year award, International Entrepreneur award and the President Ronald Regan Gold Medal. He holds M.S. and Ph.D. degrees in food technology, microbiology and (virology) with honors and distinctions from Iowa State University.
Kyle W. Rost, Attorney for international Patents.
Mr. Rost holds the degree of Juris Doctor with Honors from the University of Texas and is a senior partner with the firm of Lewis & Rost, intellectual property lawyers with offices in Denver and northern Colorado. He specializes in practice before the U.S. Patent and Trademark Office and obtains patents worldwide through his network of leading attorneys in every major country around the globe. In addition, he has taught business law and served as an expert witness in numerous federal and state courts in both patent and trademark causes. Areas of patent expertise include environmental remediation, chemistry, pharmaceuticals, biotechnology, therapeutics, probiotics, and nutraceuticals. Some of the areas where he has secured protection for leading edge technologies include cleaning geothermal steam feeding power plants while increasing turbine output, localized cleaning of aquaculture waters by application of specialized biochemical feeds in proximity to the stock in a body of water, treating water supplies with easily renewed agents to remove heavy metals, synergistic combinations of pharmaceuticals and probiotics, and treating divided food products to impart superior handling characteristics.
Daily Candlesticks
Weekly Candlesticks
| Market Value1 | $3,157,227 | a/o Jan 20, 2017 | |
| Authorized Shares | Not Available | ||
| Outstanding Shares | 96,847,458 | a/o Nov 14, 2016 | |
| -Restricted | Not Available | ||
| -Unrestricted | Not Available | ||
| Held at DTC | Not Available | ||
| Float | 60,000,000 | a/o Nov 19, 2015 | |
| Par Value | 0.001 |
